Below are 10 news articles from the past 7 days regarding COVID-19 to help guide you in making your decision. Using your best judgement, take into consideration only the articles that are most relevant for forecasting COVID-19 hospitalizations in Ontario, Canada. Articles that are from know reputable sources have been flagged with "Trusted: True".

Article 1 of 10
Title: COVID Variants: What You Should Know
Publisher: Johns Hopkins Medicine
Trusted: True
Posted: 1 day ago
Here is a summary of the article, including important facts to help forecast COVID-19 hospitalizations: Since December 2020, multiple coronavirus variants have emerged, and experts are studying their impact on transmissibility, disease severity, and vaccine effectiveness. The Omicron variant and its subvariant, BA.2 ("stealth Omicron"), are highly contagious and caused surges in COVID-19 cases, especially in areas with relaxed safety measures. Omicron has over 50 mutations, many in the spike protein, allowing it to evade weak immune responses and increase transmissibility. While Omicron may not cause more severe illness than previous variants, its high transmissibility can lead to increased hospitalizations and strain on healthcare systems. COVID-19 vaccines and boosters provide excellent protection against hospitalization and death, even against Omicron and BA.2. Staying up-to-date with vaccines is crucial. The Delta and Omicron variants have resulted in more COVID-19 cases in children, including rare severe infections and deaths. New coronavirus variants will continue to emerge as long as the virus spreads, and it's important to monitor their impact and adjust public health measures accordingly. Basic safety precautions, such as mask-wearing, physical distancing, hand hygiene, and vaccination/boosters remain crucial in reducing the risk of infection and hospitalization. To forecast COVID-19 hospitalizations, it is important to consider the impact of variants like Omicron and BA.2 on transmissibility and disease severity. Monitoring vaccination and booster rates, as well as adhering to basic safety precautions, can help mitigate the impact on healthcare systems.

Article 2 of 10
Title: Boosters are key in battle against COVID-19
Publisher: Alberta Health Services
Trusted: True
Posted: 2 days ago
Here is a summary of the article: Dr. Cora Constantinescu, a pediatric infectious disease specialist with AHS, emphasizes the importance of COVID-19 vaccine boosters in protecting against the virus, particularly the highly transmissible Omicron variant. While a large majority of Albertans have received two doses, the uptake of the third dose has been lower, which presents a missed opportunity to reduce the risk of hospitalization and severe disease. COVID-19 continues to circulate in communities, with the Omicron BA.2 subvariant dominant in Alberta, and hundreds currently hospitalized with the virus. The article highlights that booster doses significantly increase protection against severe outcomes and that vaccination is the best way to protect oneself and others, including vulnerable individuals. The safety of boosters is also emphasized, with rare adverse events reported less frequently with boosters than with second doses. Additionally, the article encourages the vaccination of children aged 5-11, noting that healthy children can also experience severe COVID-19 infections requiring hospitalization. Overall, the article stresses that it is not too late to get boosted and that vaccines continue to offer the best protection against COVID-19 and its variants. To forecast COVID-19 hospitalizations, the following facts from the article are important to consider: The uptake of booster doses among eligible Albertans is low, which may impact hospitalization rates as protection from two doses wanes over time. The highly transmissible Omicron variant, particularly the BA.2 subvariant, is dominant in Alberta, and its impact on hospitalizations should be closely monitored. Healthy children can also experience severe COVID-19 infections, and their vaccination rates are currently low, which could contribute to future hospitalizations. The article emphasizes the ongoing presence of COVID-19 in communities and the continued risk of infection and severe outcomes, suggesting that hospitalizations may remain a concern. By considering these factors, public health officials and healthcare providers can make informed decisions and prepare for potential surges in COVID-19 hospitalizations.

Article 3 of 10
Title: How COVID-19 triggers massive inflammation
Publisher: Boston Children's Discoveries
Trusted: False
Posted: 3 days ago
A recent study published in the journal Nature has revealed a potential explanation for why some individuals with COVID-19 experience severe inflammation, which can lead to respiratory distress and organ damage. The research, led by Dr. Judy Lieberman and Dr. Caroline Junqueira from Boston Children's Hospital, and Dr. Michael Filbin from Massachusetts General Hospital, discovered that the SARS-CoV-2 virus infects and kills crucial immune cells in the blood and lungs, triggering potent inflammatory signals. The team analyzed blood samples from COVID-19 patients, healthy individuals, and patients with other respiratory illnesses, as well as lung autopsy tissue from deceased COVID-19 patients. They found that the virus can infect monocytes in the blood and macrophages in the lungs, both of which act as early responders to infection. The infected immune cells undergo a form of inflammatory cell death called pyroptosis, releasing a flood of inflammatory alarm signals in the process. Interestingly, the study also suggests that antibodies produced by COVID-19 patients may paradoxically enhance infection and inflammation. Antibodies against the virus's spike protein attach to CD16 receptors, aiding the virus's entry into blood monocytes. However, antibodies generated by mRNA vaccines do not appear to facilitate this process, providing reassurance that vaccinated individuals are protected from this mechanism of inflammation. The findings have potential implications for monoclonal antibody treatment for COVID-19, offering an explanation for its effectiveness only when administered early in the disease course. By understanding the role of antibodies in promoting infection of immune cells, researchers may be able to develop more effective treatments and improve patient outcomes, particularly in severe cases of COVID-19.

Article 4 of 10
Title: Ontario Newsroom
Publisher: Government of Ontario News
Trusted: True
Posted: 3 days ago

Article 5 of 10
Title: How do I get the COVID-19 medication Paxlovid?
Publisher: CBC News
Trusted: False
Posted: 3 days ago
Here is a summary of the article: Health Canada approved the COVID-19 antiviral drug Paxlovid for use in vulnerable patients in January, but many provinces are not distributing it effectively. Despite Health Canada shipping enough doses for 150,000 people, provinces like Ontario and Alberta have only administered around 3% of their doses to patients. This is due to obstacles such as a lack of communication, coordination with healthcare providers, and accessibility issues. Paxlovid is designed for adults with mild to moderate COVID-19 symptoms who are at high risk of severe illness and hospitalization. It must be taken within five days of developing symptoms and is not for those already hospitalized with severe COVID-19. The drug combines nirmatrelvir and ritonavir, which work together to stop the coronavirus from infecting more cells. To obtain Paxlovid, a positive COVID-19 test and a prescription from a doctor or nurse practitioner are required. The process varies across provinces, with most requiring a prescription from a healthcare provider, while Quebec has authorized pharmacists to prescribe it directly. Experts emphasize that multiple levels of access and simplified procedures are necessary to ensure effective distribution. They also stress that Paxlovid is not a substitute for vaccination, and full vaccination still provides the greatest protection against severe illness. To forecast COVID-19 hospitalizations, it is important to consider the eligibility criteria for Paxlovid. These include being unvaccinated, immunocompromised, having serious underlying conditions, or being in older age groups. By monitoring the number of individuals in these high-risk categories who have not received Paxlovid, it may be possible to estimate potential hospitalizations. Additionally, understanding the factors contributing to the low distribution rates of Paxlovid can help identify areas for improvement and increase the drug's accessibility and utilization.

Article 6 of 10
Title: Why the WHO took two years to say COVID is airborne
Publisher: Nature.com
Trusted: False
Posted: 3 days ago
The World Health Organization (WHO) initially stated that SARS-CoV-2, the virus that causes COVID-19, was not transmitted through the air. This mistake led to public-health advice focusing more on sanitizing surfaces than on protecting against airborne transmission. However, as the highly contagious Omicron variant emerged and spread rapidly, the WHO finally acknowledged the airborne nature of the virus. This recognition is important as it highlights the need to focus on measures such as masking and ventilation to prevent the spread of the virus. Forecasting COVID-19 hospitalizations relies on various factors, including vaccination rates, booster shots, and the effectiveness of public health measures, such as masking and social distancing. Additionally, understanding the transmissibility and severity of new variants, as well as the availability and utilization of diagnostic testing, plays a crucial role in predicting hospitalizations.

Article 7 of 10
Title: The Impact of COVID-19 on Campus Mental Health
Publisher: Mental Health Commission of Canada
Trusted: True
Posted: 3 days ago
The article discusses the impact of the COVID-19 pandemic on the mental health of post-secondary students in Canada and the subsequent challenges for campus mental health services. A representative survey of 69 Canadian post-secondary institutions was conducted by the Campus Mental Health Community of Practice (CoP) to understand the experiences of student affairs leaders in mental health services during the 2020-21 academic year and the planning period for the fall 2022 term. The survey focused on four key areas: student mental health concerns, the transition to remote mental health services, the impact on staff, and support planning in the context of the ongoing pandemic. The survey results are being analyzed by Drs. Tayyab Rashid and Lina Di Genova, and a report on the in-depth findings will be published and made available soon.

Article 8 of 10
Title: Lower vaccination rates among people who use drugs could lead to serious outcomes from COVID-19
Publisher: UBC Faculty of Medicine
Trusted: True
Posted: 3 days ago
The article discusses the potential impact of lower vaccination rates among people who use drugs on COVID-19 hospitalizations. Here's a summary: The article highlights a concerning trend: people who use drugs have lower COVID-19 vaccination rates compared to the general population. This is a worrying development as it could lead to serious health outcomes for this vulnerable group if they contract the virus. The implications are significant as those who use drugs tend to have higher rates of underlying health conditions, putting them at an increased risk of severe COVID-19 symptoms and hospitalization. The reasons for lower vaccination rates among people who use drugs are multifaceted. The article suggests that factors such as homelessness, incarceration, and a lack of access to healthcare play a role. Additionally, stigma and discrimination might make this group hesitant to engage with healthcare providers. To address this issue and potentially reduce COVID-19 hospitalizations, public health officials and harm reduction organizations are advocating for targeted outreach and vaccination drives. These efforts aim to bring vaccines directly to this underserved population, ensuring they have access to protection against the virus. In conclusion, the article emphasizes the importance of equitable vaccine distribution and the need to prioritize vulnerable groups, including people who use drugs. By increasing vaccination rates among this population, we can help reduce the risk of severe COVID-19 outcomes and hospitalizations.

Article 9 of 10
Title: New Zealand’s Covid strategy was one of the world’s most successful – what can we learn from it? | Michael Baker and Nick Wilson
Publisher: The Guardian
Trusted: False
Posted: 5 days ago
Here is a summary of the article, including important facts to help forecast COVID-19 hospitalizations: New Zealand's COVID-19 response has been one of the most successful globally, initially adopting an elimination strategy and transitioning to a mitigation strategy as vaccines became available. The country's focus on protecting public health has resulted in low COVID-19 mortality rates and positive economic outcomes. However, the current Omicron wave has led to a peak of over 1,000 hospitalizations, and cumulative deaths are approaching 400. Key lessons from the past two years include the importance of principles such as leadership guided by science, equity, the precautionary principle, and creating legacy benefits for healthcare and public health systems. Effective communication, transparency, and political consensus have been crucial. The "team of 5 million" approach united the country during the elimination strategy. The pandemic has exposed the fragmentation and erosion of New Zealand's public health infrastructure, and health sector reforms, including the establishment of a Public Health Agency and Mori Health Authority, aim to address these issues. The country has also developed critical tools for pandemic management, such as border management systems, a national immunization register, and improved information tools for policy development and evaluation. The indoor air environment's role in transmitting respiratory infections has been a significant pandemic legacy, leading to a greater emphasis on masks and improved indoor ventilation. However, more work is needed to ensure cost-effective, year-round high-quality indoor ventilation that also provides thermal comfort. To prepare for future pandemic threats, New Zealand should maintain its focus on core principles, effective communication, consensus-building, and continuously upgrade its public health systems and tools. Accessible and effective healthcare services are also essential. To forecast COVID-19 hospitalizations, it is important to consider the high infection rate of the Omicron variant, the severity of the disease, and the vaccination coverage of the population. The article suggests that New Zealand will need to maintain and strengthen controls to manage the impact of future waves.

Article 10 of 10
Title: New funding ensures Ontario Tech researchers will continue to monitor COVID-19 and other indicators of health in wastewater
Publisher: News
Trusted: False
Posted: 5 days ago
Here is a summary of the article: Ontario Tech University's Faculty of Science has been collecting and testing untreated sewage samples for traces of COVID-19 since June 2020. The program, which was set to expire in March, has been extended and expanded with new funding from the Province of Ontario and the New Frontiers in Research Fund (NFRF). The university is receiving a total of $250,000 in federal funding to study indicators of gastrointestinal disease and $24.7 million to continue the Wastewater Surveillance Initiative (WSI) through March 2023. The key highlights of the article include: Ontario Tech researchers have been examining wastewater collected from multiple water pollution control plants in the Durham Region, Simcoe County, and Muskoka Region. The data collected has helped officials determine appropriate steps to limit or prevent further infection in the community. The new funding will support the development of new methods to study small biomolecules as indicators of community health, including opioid use and COVID-19 hospitalizations. The wastewater testing program has been a valuable tool for monitoring trends and detecting outbreaks early, especially as regular individual testing has become less frequent. The initiative produces reliable results for local public health units and currently takes place in more than 170 locations across the province, covering 75% of Ontario’s population. This article highlights the importance of wastewater testing as a tool for public health and the potential for it to be used to forecast COVID-19 hospitalizations and identify new coronavirus hotspots.